MSD has said it will cut $3 billion off its annual costs by the end of 2027 as it prepares for the end of patent protection for blockbuster cancer drug Keytruda the following year. The plan was ...

Some restaurants offer elaborate horse-themed Yusheng, like Jade's $888++ Premium Winning Horse Yu Sheng, despite the labour and skill required. A trend this year highlights large-format Yusheng ...

The investment from BDT & MSD Partners will support Designs for Health’s continued growth, product innovation, and commitment to supporting practitioners and patients with clinical education and ...

MSD exercises its option on vaccine candidate EVX-B3 for a cash payment of $7.5 million, which extend Evaxion’s cash runway to first half of 2027 MSD will assume full responsibility for the further ...

HEICO Corporation (NYSE:HEI) will release earnings results for the third quarter, after the closing bell on Monday, Aug. 25. Analysts expect the Hollywood, Florida-based company to report quarterly ...

The pace of M&A in the pharma sector this year has picked up once again, with MSD agreeing a takeover offer for respiratory medicine specialist Verona Pharma that values the company at around $10 ...

Phase I Study of 131I-Metaiodobenzylguanidine With Dinutuximab ± Vorinostat for Patients With Relapsed or Refractory Neuroblastoma: A New Approaches to Neuroblastoma Therapy Trial While the ...

Home Equity Investment (HEI) is a relatively new option for private equity real estate investors, and one that carries significant promise. Essentially, is a secured contract where a homeowner ...

BDT & MSD Partners alum Adam Piekarski is starting anew and has formed Derby Lane Partners, a new real estate credit investment firm, according to a person with knowledge of the matter. New York-based ...

Merck & Co (MSD) has begun construction on a $1bn biologics centre of excellence, Merck Wilmington Biotech, in Delaware, US. The 470,000ft² facility is set to bolster the company's biologics and ...